Telomerase as a potential molecular target to study G-quartet phosphorothioates

Antisense and Nucleic Acid Drug Development

Volumn 6, Issue 1, 1996, Pages 3-7

  Sharma, Harsh W ^a   Hsiao, Rongshen ^a   Narayanan, Ramaswamy ^a  

^a HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; RIBONUCLEOPROTEIN; RNA DIRECTED DNA POLYMERASE; TELOMERASE;

ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; ENZYME INHIBITION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0029975255     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1996.6.3     Document Type: Article

References (23)

1. bcr-abl tyrosine kinase autophosphorylation by oligodeoxynucleotides of defined sequence and backbone structure. Nucleic Acids Res. 22, 2150-2154.
2. BLACKBURN, E.H. (1992). Telomerases. Annu. Rev. Biochem. 61, 113-129.
3. BRANDA, R.F., MOORE, A.L., MATHEWS, L., McCORMACK, J.J., and ZON, G. (1993). Immune stimulation by an antisense oligomer complementary to the rev gene of HIV-I. Biochem. Pharmacol. 45, 2037-2043.
4. BROWN, D.A., KANG, S.H., GRYAZNOV, S.M., DEDIONISIO, L., HEIDENREICH, O., SULLIVAN, S., XU, X., and NERENBERG, M.I. (1994). Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding. J. Biol. Chem. 269, 26801-26805.
5. BURGESS, T.L., FISHER, E.F., ROSS, S.L., BREADY, J.V., QIAN, Y., BAYEWITCH, L.A., COHEN, A.M., HERRERA, C.J., HU, S.S., KRAMER, T.B., LOTT, F.D., MARTIN, F.H., PIERCE, G.F., SIMONET, L., and FARRELL, C.L. (1995). The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc. Natl. Acad. Sci. USA 92, 4051-4055.
6. De LANGE, T. (1994). Activation of telomerase in a human tumor. Proc. Natl. Acad. Sci. USA 91, 2882-2885.
7. GAO, W.Y., HAN, F.S., STORM, C., EGAN, W., and CHENG, Y.C. (1992). Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: Implications for antisense technology. Mol. Pharmacol. 41, 223-229.
8. GILES, R.V., SPILLER, D.G., and TIDD, D.M. (1993). Chimeric oligodeoxynucleotide analogues: Enhance cell uptake of structures which direct ribonuclease H with high specificity. Anticancer Drug Res. 8, 33-51.
9. KIM, N.W., PIATYSZEK, M.A., PROWSE, K.R., HARLEY, C.B., WEST, M.D., HO, P.L., COVIELLO, G.M., WRIGHT, W.E., WEINRICH, S.L., and SHAY, J.W. (1994). Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015.
10. KRIEG, A.M., YI, A.K., MATSON, S., WALDSCHMIDT, T.J., BISHOP, G.A., TEASDALE, R., KORETZKY, G.A., and KLINMAN, D.M. (1995). CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546-549.
11. MALTESE, J.Y., VASSILEV, L., SHARMA, H.W., and NARAYANAN, R. (1995). Sequence context of antisense RelA/NF-κB phosphorothioates determines specificity. Nucleic Acids Res. 7, 1146-1151.
12. MAURY, G., ABDELAZIZ, E., MORVAN, F., MULLER, B., IMBACH, J., and GOODY, R.S. (1992). Template, phosphorothioate oligonucleotides duplexes as inhibitors of HIV-1 reverse transcriptase. Biochem. Biophys. Res. Commun. 186, 1249-1256.
13. McINTYRE, K.W., LOMBARD-GILLOOLY, K., PEREZ, J.R., KUNSCH, C., SARMIENTO, U.M., LARIGAN, J.D., LANDRETH, K.T., and NARAYANAN, R. (1993). A sense phosphorothioate oligonucleotide directed to the initiation codon of transcription factor NF-κB p65 causes sequence-specific immune stimulation. Antisense Res. Dev. 3, 309-322.
14. MORIN, G.B. (1989). The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59, 521-529.
15. NARAYANAN, R., HIGGINS, K.A., PEREZ, J.R., COLEMAN, T.A., and ROSEN, C.A. (1993). Evidence for differential functions of the p50 and p65 subunits of NF-κB using a cell adhesion model. Mol. Cell Biol. 13, 3802-3810.
16. PEREZ, J.R., LI, Y., STEIN, C.A., MAJUMDER, S., VAN OORSCHOT, A., and NARAYANAN, R. (1994). Sequence independent induction of Sp-1 transcription factor by phosphorothioate oligodeoxynucleotides. Proc. Natl. Acad. Sci. USA 91, 5957-5961.
17. SHARMA, H.W., and NARAYANAN, R. (1995). The therapeutic potential of antisense oligodeoxynucleotides. BioEssays 17, 1055-1063.
18. STEIN, C.A., and CHENG, Y.C. (1993). Antisense oligonucleotides as therapeutic agents - Is the bullet really magical? Science 261, 1004-1012.
19. STEIN, C.A., and NARAYANAN, R. (1994). Antisense oligonucleotides. Curr. Opin. Oncol. 6, 587-594.
20. STEIN, C.A., TONKINSON, J.L., ZHANG, L.M., YAKUBOV, L., GERVASONI, J., TAUB, R., and ROTENBERG, S.A. (1993). Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells. Biochemistry 32, 4855-4861.
21. TEASDALE, R.M., MATSON, S.J., FISHER, E., and KRIEG, A.M. (1994). Inhibition of T4 polynucleotide kinase activity by phosphorothioate and chimeric oligodeoxynucleotides. Antisense Res. Dev. 4, 295-297.
22. WICKSTROM, E., BACON, T., and WICKSTROM, E.L. (1992). Down-regulation of c-MYC antigen expression in lymphocytes of Emu-c-myc transgenic mice treated with anti-c-myc DNA methylphosphonates. Cancer Res. 52, 6741-6745.
23. YASWEN, P., STAMPFER, M.R., GHOSH, K., and COHEN, J.S. (1993). Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells. Antisense Res. Dev. 3, 67-77.